Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Usana Health Sciences (USNA) Gross Margin (2016 - 2026)

Usana Health Sciences has reported Gross Margin over the past 17 years, most recently at 76.25% for Q2 2026.

  • Quarterly Gross Margin fell 274.0% to 76.25% in Q2 2026 from the year-ago period, while the trailing twelve-month figure was 77.55% through Apr 2026, down 298.0% year-over-year, with the annual reading at 78.29% for FY2026, 284.0% down from the prior year.
  • Gross Margin was 76.25% for Q2 2026 at Usana Health Sciences, down from 78.16% in the prior quarter.
  • Over five years, Gross Margin peaked at 81.95% in Q4 2024 and troughed at 76.25% in Q2 2026.
  • The 5-year median for Gross Margin is 80.43% (2023), against an average of 80.02%.
  • Year-over-year, Gross Margin skyrocketed 123bps in 2023 and then crashed -379bps in 2026.
  • A 5-year view of Gross Margin shows it stood at 79.63% in 2022, then rose by 2bps to 80.86% in 2023, then grew by 1bps to 81.95% in 2024, then fell by -6bps to 77.15% in 2025, then dropped by -1bps to 76.25% in 2026.
  • Per Business Quant, the three most recent readings for USNA's Gross Margin are 76.25% (Q2 2026), 78.16% (Q1 2026), and 77.15% (Q3 2025).